Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 3560238, 6 pages
https://doi.org/10.1155/2017/3560238
Review Article

Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy

1Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
2Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, RI, USA

Correspondence should be addressed to Shougang Zhuang; gro.napsefil@gnauhzs

Received 30 November 2016; Accepted 20 February 2017; Published 23 April 2017

Academic Editor: Secundino Cigarran

Copyright © 2017 Na Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Gnudi, R. J. Coward, and D. A. Long, “Diabetic nephropathy: perspective on novel molecular mechanisms,” Trends in Endocrinology & Metabolism, vol. 27, no. 11, pp. 820–830, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. M. Yasuda, S. Kume, A. Tagawa, H. Maegawa, and T. Uzu, “Emerging role of podocyte autophagy in the progression of diabetic nephropathy,” Autophagy, vol. 11, no. 12, pp. 2385–2386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Ding and M. E. Choi, “Autophagy in diabetic nephropathy,” The Journal of Endocrinology, vol. 224, no. 1, pp. R15–R30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. N. A. Calcutt, M. E. Cooper, T. S. Kern, and A. M. Schmidt, “Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials,” Drug Discovery, vol. 8, no. 5, pp. 417–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. B. M. Brenner, M. E. Cooper, D. de Zeeuw et al., “Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy,” New England Journal of Medicine, vol. 345, no. 12, pp. 861–869, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Har, J. W. Scholey, D. Daneman et al., “The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus,” Diabetologia, vol. 56, no. 5, pp. 1166–1173, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Bhattacharjee, S. Barma, N. Konwar, S. Dewanjee, and P. Manna, “Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update,” European Journal of Pharmacology, vol. 791, pp. 8–24, 2016. View at Publisher · View at Google Scholar
  9. T. W. Tervaert, A. L. Mooyaart, K. Amann et al., “Pathologic classification of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 21, no. 4, pp. 556–563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. B. M. Brenner, M. E. Cooper, D. de Zeeuw et al., “Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy,” The New England Journal of Medicine, vol. 345, no. 12, pp. 861–869, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Ravikumar, S. Sarkar, J. E. Davies et al., “Regulation of mammalian autophagy in physiology and pathophysiology,” Physiological Reviews, vol. 90, no. 4, pp. 1383–1435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Liu, Y. F. Shi, and S. G. Zhuang, “Autophagy in chronic kidney diseases,” Kidney Diseases, vol. 2, no. 1, pp. 37–45, 2016. View at Publisher · View at Google Scholar
  13. N. Mizushima, T. Yoshimori, and B. Levine, “Methods in mammalian autophagy research,” Cell, vol. 140, no. 3, pp. 313–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Kaushik and A. M. Cuervo, “Chaperone-mediated autophagy: a unique way to enter the lysosome world,” Trends in Cell Biology, vol. 22, no. 8, pp. 407–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Beau, A. Esclatine, and P. Codogno, “Lost to translation: when autophagy targets mature ribosomes,” Trends in Cell Biology, vol. 18, no. 7, pp. 311–314, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Kraft, F. Reggiori, and M. Peter, “Selective types of autophagy in yeast,” Biochimica et Biophysica Acta, vol. 1793, no. 9, pp. 1404–1412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. van der Vaart, M. Mari, and F. Reggiori, “A picky eater: exploring the mechanisms of selective autophagy in human pathologies,” Traffic, vol. 9, no. 3, pp. 281–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Mizushima, “The role of the Atg1/ULK1 complex in autophagy regulation,” Current Opinion in Cell Biology, vol. 22, no. 2, pp. 132–139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. I. G. Ganley, H. Lam, J. Wang, X. Ding, S. Chen, and X. Jiang, “ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy,” The Journal of Biological Chemistry, vol. 284, no. 18, pp. 12297–12305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Majmundar, W. J. Wong, and M. C. Simon, “Hypoxia-inducible factors and the response to hypoxic stress,” Molecular Cell, vol. 40, no. 2, pp. 294–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Kouroku, E. Fujita, and I. Tanida, “ER stress (PERK/eIF2α phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation,” Cell Death and Differentiation, vol. 14, no. 2, pp. 230–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Y. Kim, S. A. Nam, H. C. Song et al., “The role of autophagy in unilateral ureteral obstruction rat model,” Nephrology (Carlton), vol. 17, no. 2, pp. 148–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Zhu, K. Wang, and C. Chu, “After the banquet: mitochondrial biogenesis, mitophagy and cell survival,” Autophagy, vol. 9, no. 11, pp. 1–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Suzuki, “Selective autophagy in budding yeast,” Cell Death and Differentiation, vol. 20, no. 1, pp. 43–48, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Wang and M. E. Choi, “Autophagy in kidney health and disease,” Antioxidants & Redox Signaling, vol. 20, no. 3, pp. 519–537, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Geng and D. J. Klionsky, “The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. ‘Protein modifications: beyond the usual suspects’ review series,” EMBO Reports, vol. 9, no. 9, pp. 859–864, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Liu, Q. X. Li, X. J. Wang et al., “Beta-arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy,” Cell Death & Disease, vol. 7, no. 4, article e2183, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Hosokawa, T. Hara, T. Kaizuka et al., “Nutrient-dependent mTORCl association with the ULK1-Atg13-FIP200 complex required for autophagy,” Molecular Biology of the Cell, vol. 20, no. 7, pp. 1981–1991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. H. Jung, C. B. Jun, S. H. Ro et al., “ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery,” Molecular Biology of the Cell, vol. 20, no. 7, pp. 1992–2003, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Yamahara, M. Yasuda, S. Kume, D. Koya, H. Maegawa, and T. Uzu, “The role of autophagy in the pathogenesis of diabetic nephropathy,” Journal of Diabetes Research, vol. 2013, Article ID 193757, p. 9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P. E. Burnett, R. K. Barrow, N. A. Cohen, S. H. Snyder, and D. M. Sabatini, “RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 4, pp. 1432–1437, 1998. View at Google Scholar
  32. M. Laplante and D. M. Sabatini, “mTOR signaling in growth control and disease,” Cell, vol. 149, no. 2, pp. 274–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Domin and M. D. Waterfield, “Using structure to define the function of phosphoinositide 3-kinase family members,” FEBS Letters, vol. 410, no. 1, pp. 91–95, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. J. A. Engelman, J. Luo, and L. C. Cantley, “The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism,” Nature Reviews Genetics, vol. 7, no. 8, pp. 606–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Mandl-Weber, C. D. Cohen, B. Haslinger, M. Kretzler, and T. Sitter, “Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells,” Kidney International, vol. 61, no. 2, pp. 570–578, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Kihara, T. Noda, N. Ishihara, and Y. Ohsumi, “Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae,” The Journal of Cell Biology, vol. 152, no. 3, pp. 519–530, 2001. View at Publisher · View at Google Scholar
  37. A. Simonsen and S. A. Tooze, “Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes,” Journal of Cell Biology, vol. 186, no. 6, pp. 773–782, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Vergne, E. Roberts, R. A. Elmaoued et al., “Control of autophagy initiation by phosphoinositide 3-phosphatase jumpy,” The EMBO Journal, vol. 28, no. 15, pp. 2244–2258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. T. F. Franke, D. R. Kaplan, L. C. Cantley, and A. Toker, “Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate,” Science, vol. 275, no. 5300, pp. 665–668, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. D. D. Sarbassov, S. M. Ali, and D. M. Sabatini, “Growing roles for the mTOR pathway,” Current Opinion in Cell Biology, vol. 17, no. 6, pp. 596–603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. D. G. Hardie, “AMPK: a key regulator of energy balance in the single cell and the whole organism,” International Journal of Obesity, vol. 32, Supplement 4, pp. S7–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. B. B. Zhang, G. Zhou, and C. Li, “AMPK: an emerging drug target for diabetes and the metabolic syndrome,” Cell Metabolism, vol. 9, no. 5, pp. 407–416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Sanders, P. O. Grondin, B. D. Hegarty, M. A. Snowden, and D. Carling, “Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade,” The Biochemical Journal, vol. 403, no. 1, pp. 139–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Jin, S. Liu, Q. Ma, D. Xiao, and L. Chen, “Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes,” European Journal of Pharmacology, vol. 794, pp. 106–114, 2016. View at Publisher · View at Google Scholar
  45. D. Li, Z. Lu, Z. Xu et al., “Spironolactone promotes autophagy via inhibiting PI3K:AKT:mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress,” Bioscience Reports, vol. 36, no. 4 article e00355, 2016. View at Publisher · View at Google Scholar
  46. H. Pópulo, J. M. Lopes, and P. Soares, “The mTOR signalling pathway in human cancer,” International Journal of Molecular Sciences, vol. 13, no. 2, pp. 1886–1918, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Arns, K. Budde, F. Eitner et al., “Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - an update of existing recommendations,” Deutsche Medizinische Wochenschrift, vol. 136, no. 49, pp. 2554–2559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Madke, “Topical rapamycin (sirolimus) for facial angiofibromas,” Indian Dermatology Online Journal, vol. 4, no. 1, pp. 54–57, 2013. View at Publisher · View at Google Scholar
  49. L. Liu, D. R. Wise, J. A. Diehl, and M. C. Simon, “Hypoxic reactive oxygen species regulate the integrated stress response and cell survival,” Journal of Biological Chemistry, vol. 283, no. 45, pp. 31153–31162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Ma, J. L. Zhu, X. H. Chen, D. Zha, P. C. Singhal, and G. Ding, “High glucose induces autophagy in podocytes,” Experimental Cell Research, vol. 319, no. 6, pp. 779–789, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Yadav, S. Vallabu, S. Arora et al., “ANG II promotes autophagy in podocytes,” American Journal of Physiology Cell Physiology, vol. 299, no. 2, pp. C488–C496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. M. B. Azad, Y. Chen, and S. B. Gibson, “Regulation of autophagy by reactive oxygen species (ROS) implications for cancer progression and treatment,” Antioxidants & Redox Signaling, vol. 11, no. 4, pp. 777–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Fang, Y. Zhou, H. Cao et al., “Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia-induced podocyte injury,” PloS One, vol. 8, no. 4, article e60546, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. P. L. Tharaux and T. B. Huber, “How many ways can a podocyte die?” Seminars in Nephrology, vol. 32, no. 4, pp. 394–404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Oltean, Y. Qiu, J. K. Ferguson et al., “Vascular endothelial growth factor-A165b is protective and restores endothelial glycocalyx in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 26, no. 8, pp. 1889–1904, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Shen, C. Tian, H. Chen et al., “Oxidative stress mediates chemerin-induced autophagy in endothelial cells,” Free Radical Biology & Medicine, vol. 55, pp. 73–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Du, R. J. Teng, T. Guan et al., “Role of autophagy in angiogenesis in aortic endothelial cells,” American Journal of Physiology. Cell Physiology, vol. 302, no. 2, pp. C383–C391, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. W. Miaomiao, L. Chunhua, Z. Xiaochen, C. Xiaoniao, L. Hongli, and Y. Zhuo, “Autophagy is involved in regulating VEGF during high-glucose-induced podocyte injury,” Molecular BioSystems, vol. 12, no. 7, pp. 2202–2212, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Y. Yang, N. H. Kim, Y. S. Cho, H. Lee, and H. J. Kwon, “Convallatoxin, a dual inducer of autophagy and apoptosis, inhibits angiogenesis in vitro and in vivo,” PloS One, vol. 9, no. 3, article e91094, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Liu, S. Yu, H. Zhang, and J. Xu, “Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2,” PloS One, vol. 7, no. 10, article e46720, 2012. View at Publisher · View at Google Scholar · View at Scopus